[A comparative analysis on the efficacy of sumamigren in treatment menstrual and non-menstrual migraine attacks].
Based on the headache diaries, authors compared clinical presentations, degree of disability and efficacy of sumamigren (sumatriptan) in treatment menstrual and non-menstrual migraine attacks in 27 women (mean age 35 ± 1.7 years). The diagnosis of menstrual-associated migraine was made in accordance with a supplement to the International Classification of Headache Disorders. 2nd edition. The clinical characteristics and degree of reduction of disability in menstrual and non-menstrual migraine attacks did not differ during the treatment. Efficacy of sumamigren was comparable in both types of attacks.